Laboratory of Food Safety and Molecular Biology, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, PR China.
Regul Toxicol Pharmacol. 2010 Dec;58(3):474-81. doi: 10.1016/j.yrtph.2010.08.018. Epub 2010 Aug 27.
The Cry1C protein produced in Escherichia coli was used for in vitro evaluation and animal studies to support the safety assessment of GM food or feed products containing the Cry1C protein. The Cry1C protein does not have any sequence homology with known allergens or toxins. Although the Cry1C protein was heat stable it was rapidly degraded in vitro with simulated gastric or intestinal fluids. It did not cause adverse effects in mice as administered by gavage at a high level dosage of 5 g (Cry1C protein)/kg body weight. The mutagenicity of this protein was evaluated according to the national standards of People's Republic of China (PR China) for a new food resource. In mutagenic tests, the Cry1C protein caused<4 micronucleated cells per 1000 cells, <16 sperm abnormalities per 1000 cells and was not associated with any increased mutations in the Ames test. Taken together, these data indicate that the Cry1C protein is not a potential allergen or toxin.
Cry1C 蛋白在大肠杆菌中表达,用于体外评估和动物研究,以支持含有 Cry1C 蛋白的转基因食品或饲料产品的安全性评估。Cry1C 蛋白与已知的过敏原或毒素没有任何序列同源性。虽然 Cry1C 蛋白具有热稳定性,但在模拟胃液或肠液中迅速降解。经灌胃给予 5 g(Cry1C 蛋白)/kg 体重的高剂量时,该蛋白在小鼠体内未引起不良反应。根据中国(PR China)新食品资源国家标准对该蛋白的致突变性进行了评估。在致突变试验中,Cry1C 蛋白引起<4 个微核细胞/1000 个细胞,<16 个精子异常/1000 个细胞,与 Ames 试验中任何增加的突变无关。综上所述,这些数据表明 Cry1C 蛋白不是潜在的过敏原或毒素。